echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Another province determines the execution time of "4 + 7" expansion results

    Another province determines the execution time of "4 + 7" expansion results

    • Last Update: 2019-10-29
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    In order to thoroughly implement the decision-making and deployment of the Party Central Committee and the State Council, and comprehensively promote the implementation of the pilot work of centralized drug purchase and use organized by the state in our province, according to the notice of the general office of the State Council on printing and distributing the pilot program of centralized drug purchase and use organized by the state (GBF [2019] No.2), the notice of the State Medical Insurance Bureau and other nine departments on centralized drug purchase and use organized by the state In the spirit of the opinions on the implementation of the pilot project of purchasing and using drugs to expand the regional scope (CMFA [2019] No 56) and the opinions of the State Medical Security Bureau on the supporting measures for the pilot project of centralized purchasing and using drugs organized by the state (CMFA [2019] No 18), and in combination with the actual situation of Jiangsu Province, our bureau has formulated the plan of promoting the implementation of the pilot project of centralized purchasing and using drugs organized by the state in Jiangsu Province The implementation plan of domain wide work (Draft for comments) is now open to the public for comments Relevant opinions and suggestions shall be fed back to the medical price and bidding procurement office of Provincial Medical Security Bureau by email, fax, letter and other forms before November 5 Email: jsswjjgjc@163.com Fax: 025-83290268 contact address: room 211, medical price and bidding procurement office, Jiangsu Medical Security Bureau (building 10, No 168, Jianye Road, Qinhuai District, Nanjing 210004), Jiangsu Medical Security Bureau, October 28, 2019, Jiangsu Province to promote the implementation of the national organization drug centralized procurement and use pilot work to expand the regional scope (Draft for comments) In order to ensure the full implementation of the task of national organization drug centralized procurement and use pilot to expand the regional scope (hereinafter referred to as "pilot expansion") in our province, according to the notice of the general office of the State Council on printing and distributing the pilot program of national organization drug centralized procurement and use (GBF [2019] No The implementation plan is formulated in the spirit of the implementation opinions on pilot expansion of regional scope (medical insurance Fa [2019] No 56) and the opinions of the State Medical Insurance Bureau on the supporting measures for centralized drug procurement and use pilot medical insurance (medical insurance Fa [2019] No 18) in combination with the actual situation of our province 1、 General requirements (I) main objectives Comprehensively promote the implementation of pilot expansion work, so that qualified medical institutions can provide high-quality and cheap pilot drugs, so that the reform results can benefit more people; achieve a significant reduction in drug prices, reduce the burden of patients' drug costs; reduce the transaction costs of enterprises, purify the circulation environment, improve the industry ecology; guide medical institutions to regulate drug use, support the reform of public hospitals; explore and improve drugs Centralized purchase mechanism and market-oriented drug price formation mechanism (2) Overall thinking According to the general idea of national organization, alliance procurement and platform operation, and under the framework of national unified organization, unified deployment and unified policy, with the provincial public medical institutions as the main body of centralized procurement, steadily promote the pilot expansion, and comprehensively implement the results of centralized procurement of drugs organized by the state (3) Basic principles First, we should take the people as the center, ensure the demand of clinical medication, reduce the burden of patients and ensure the quality and supply of drugs Second, adhere to the combination of market mechanism and government role, not only respect the market-oriented drug price formation mechanism, but also better play the role of the government in building a platform, promoting docking, ensuring supply and strengthening supervision Third, adhere to smooth transition and proper connection, and properly handle the relationship between pilot expansion and existing procurement policies Fourth, we should adhere to the integration of departments, take multiple measures at the same time, and strengthen the construction of a comprehensive regulatory system for procurement, use, settlement, payment and other aspects 2、 Implementation scope and procurement cycle (I) organization scope All public medical institutions in the province, military medical institutions participating in the pilot expansion, designated social medical institutions and designated retail pharmacies voluntarily participating in the pilot expansion (2) Drug range The state organizes the centralized purchase and use of 25 generic drugs selected from the pilot projects (3) Term of the agreement According to the number of selected enterprises, the procurement cycle of selected drugs is one year and two years respectively, which can be extended for one year depending on the actual situation 3、 Policies and measures (1) purchase with quantity and exchange price with quantity According to 50% - 70% of the 25 drugs used in the pilot expansion of the relevant medical institutions in our province last year, calculate the total agreed purchase amount of the selected drugs, carry out the volume purchase, and implement the total agreed purchase amount of the selected drugs to the medical institutions at all levels According to the selected price, the relevant medical institutions sign a volume purchase and sales contract with the selected enterprises, which is signed once a year For the remaining consumption beyond the agreed purchase, the relevant medical institutions can still purchase other online varieties with appropriate price through the provincial drug centralized purchase platform For the 25 generic drugs included in the pilot expansion, if there are more than 3 manufacturers of the same type of drugs that have passed the consistency evaluation of quality and efficacy, the varieties that have failed the consistency evaluation will not be used in the centralized purchase of drugs under the condition of ensuring the supply (2) The combination of bidding and mining ensures the use Each relevant medical institution shall give priority to the use of the selected varieties, and complete the requirements of the contract amount and the agreed purchase proportion within the agreement period in accordance with the provisions of the volume purchase and sale contract After the purchase quantity is completed, the selected varieties shall still be used preferentially (3) Quality first, supply guaranteed As the first person responsible for ensuring quality and supply, the medium-sized enterprises shall strictly carry out quality management, independently select distribution enterprises with good distribution ability and reputation, and establish emergency reserve, inventory and shutdown reporting system for production enterprises in accordance with the purchase and sales contract Relevant departments shall strengthen the whole chain quality supervision over the production, circulation and use of the selected drugs, strengthen the production and inventory monitoring, prevent the behavior of reducing the quality of drugs due to the price drop, and ensure the quality and supply of drugs In addition to the force majeure factors, the selected enterprises with quality and supply problems shall bear the additional costs incurred by replacement, otherwise it will be deemed as dishonest behavior All products of the relevant dishonest enterprises shall not participate in the procurement of drugs and medical consumables in all public medical institutions in the whole province within two years (4) Guarantee collection and reduce transaction cost As the first person in charge of drug payment settlement, the medical institution shall settle with the enterprise in time according to the provisions of the contract to reduce the transaction cost of the enterprise In principle, the period from the qualified delivery and acceptance of drugs to the payment shall not exceed 30 days, and the problem of the medical institution's failure to settle the drug payment on time shall be strictly investigated The medical insurance agency shall pay the medical insurance expenses to the medical institution in time On the basis of the total budget of the medical insurance fund, the medical insurance agencies of each overall planning area shall prepay to the medical institutions at least 30% of the purchase amount in advance After the agreed purchase amount is completed, it shall continue to prepay in combination with the actual purchase amount of the selected drugs, and the medical institutions shall continue to ensure timely repayment (5) To explore the coordination of medical insurance payment standard and purchase price For the drugs purchased in a centralized way, the payment standard for medical insurance is the price of the drugs purchased in a centralized way within the scope of the medical insurance drug catalog In principle, for the original research drugs, reference preparations and generic drugs under the same general name, the medical insurance fund will be settled according to the same payment standard If the price of drugs used by patients is higher than the payment standard, the part exceeding the payment standard shall be paid by the patients themselves, and the part within the payment standard shall be reimbursed by the medical insurance according to the regulations If the price of drugs used by patients is quite different from the centralized purchase price of selected drugs, the payment standard shall be adjusted gradually, adjusted in place within 2-3 years, and supporting measures shall be formulated; if the price of drugs used by patients is lower than the payment standard, Pay according to the actual price On the basis of ensuring the quality and supply, guide the medical institutions and patients to form reasonable medication habits (6) Through mechanism transformation, we will promote the reform of medical institutions We will deepen the reform of payment methods for medical insurance, establish an incentive and risk sharing mechanism for "surplus retention and reasonable overspending sharing" between medical insurance agencies and medical institutions, and promote medical institutions to use the drugs with appropriate prices For the designated medical institutions that reasonably use the selected drugs, perform the purchase and sale contract, and complete the consumption of drugs purchased in a centralized way, the total amount control index of the purchase contract within one year will not be reduced due to the decrease of the cost of drugs purchased in a centralized way, and for the designated medical institutions that fail to normally complete the purchase of selected drugs within the contract period when the purchase results are implemented, the amount of medical insurance cost in the next year will be deducted accordingly We will continue to push forward the payment by disease type, disease diagnosis related groups, bed days and other quotas, and will not reduce the annual quota payment standard for the use of centrally purchased drugs due to the decrease of drug costs If the balance of medical service revenue and expenditure of public medical institutions is formed, it can be used as a whole for personnel salary according to the requirements of "two permits" (allowing medical and health institutions to break through the current wage control level of public institutions, allowing medical service revenue to deduct costs and withdraw various funds according to regulations, which are mainly used for personnel rewards) (7) Mobilize the enthusiasm of medical institutions and ensure the dosage We will encourage the use of drugs selected through centralized procurement, and incorporate the use of selected drugs into the performance appraisal and medical insurance agreement management of medical institutions and medical personnel All relevant departments and medical institutions shall not influence the reasonable use and supply guarantee of the selected drugs on the grounds of cost control, requirements for drug varieties, specifications and quantities of medical institutions, examination and approval of Pharmaceutical Affairs Committee, etc For the medical institutions that do not purchase and use drugs according to the regulations, they shall be punished in the total amount index of medical insurance, the performance evaluation of medical institutions, the qualification of designated medical insurance and the objective responsibility evaluation of the person in charge of medical institutions The medical personnel who do not use the selected drugs according to the regulations shall be seriously dealt with in accordance with the corresponding provisions of the prescription management measures and the hospital prescription evaluation management standard (Trial) We will strengthen the role of clinical pharmacists in the review of prescription dispensing, and promote the priority use of selected drugs We should further improve the guidelines for clinical application of drugs, strengthen the monitoring of drug use in medical institutions, strictly review and comment on prescriptions, strengthen the publicity and training of doctors and clinical pharmacists, organize and carry out comprehensive clinical evaluation of drugs, promote scientific and rational use of drugs, and ensure the safety of drug use for patients 4、 Organizational support (1) clear responsibilities of departments The competent departments of medical insurance, medical treatment and medicine should perform their respective duties, coordinate and coordinate to ensure the smooth implementation of pilot expansion The provincial medical insurance bureau is responsible for formulating the pilot expansion work plan, relevant supporting policies for medical insurance and supervising the implementation, and guiding the local medical insurance departments to do a good job in the agreed purchase volume decomposition, medical insurance payment, settlement and total budget management The provincial health and Health Commission is responsible for strengthening the guidance and supervision of public medical institutions in the use of selected drugs, urging public medical institutions to prioritize the purchase and use of selected drugs, and completing the agreed purchase volume within the contract period Carry out publicity and training for doctors to improve the rational use of selected drugs The implementation of on-line procurement in public medical institutions will be included in the performance appraisal of medical institutions We will do a good job in monitoring the clinical use of selected drugs, monitoring and warning drug shortage information, and guiding the reform of public hospitals The provincial drug administration is responsible for the quality supervision of the production, circulation and use of the selected drugs, strengthening the supervision and inspection of the selected drug production enterprises in the province, and urging the production enterprises to implement the stop production reporting measures The Provincial Department of industry and information technology is responsible for urging the pharmaceutical enterprises in the province to implement the responsibility of production and supply, supporting the enterprises to carry out production technology transformation, and improving the supply guarantee capacity of the selected drugs The Provincial Department of Commerce strengthened the guidance of drug circulation The provincial market supervision and administration bureau is responsible for cracking down on acts disturbing fair competition in the market and strengthening medicine
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.